In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With The Launch Of Yervoy, Early Signs Of R&D Success For Bristol

Executive Summary

Four years ago, Bristol management changed course and established the company as a pure play biopharma. Now, with the launch of Yervoy for metastatic melanoma and a late-stage pipeline that is chock-full, the strategy appears about to pay off. CEO Lamberto Andreotti and R&D president Elliott Sigal talked with IN VIVO about the launch of Yervoy and how Bristol, relying on R&D productivity, not diversification, is on track to overcome the extensive patent losses ahead.
Advertisement

Related Content

ASCO 2011: The Rapidly Changing Melanoma Market
Bristol Basks In Broad Ipilimumab Label, Sets High Price
Can BMS Deliver on Innovation?
Can BMS Deliver on Innovation?
Why Doesn't Pharma Get Smaller?
Why Doesn't Pharma Get Smaller?
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
Bristol Revs Its R&D Engine: An Interview with Elliott Sigal and Francis Cuss
Bristol Revs Its R&D Engine: An Interview with Elliott Sigal and Francis Cuss

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel